1Gupta SK, Douglas-Jones AG, Fenn N, et al. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (drctal carcinoma in situ). Cancer , 1997,80 ( 9 ) : 1740-1745.
2Silverstein M J, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma- in- situ. Lancet , 1995,345 ( 8958 ) : 1154- 1157.
3Poelman SM, Heimarm R, Fleming GF, et al. Invariant p53 immunostaining in primary and recurrent breast cancer[]]. Eur J Cancer, 2004, 40(1): 28-32.
4Heiser D, Labi V, Erlacher M, et al. The Bcl-2 protein family and its role in the development of neoplastic disease[J]. Exp Gerontol, 2004, 39(8): 1125-1135.
5Nadler Y, Camp RL, Gilmane JM, et al. Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer[J]. Breast Cancer Res, 2008, 10(2): 35.
